￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Dosage and usage for patients with the targeted drug Tepotinib

2026-02-01 22:25:32

Check Details
Clinical manifestations and efficacy of olaparib (Olaparib, Lipadro) combined with temozolomide

2026-02-01 22:25:32

Check Details
What to do if you become drug-resistant to Lynparza (Olaparib, Lipadro)

2026-02-01 22:25:32

Check Details
Can Lynparza (Olaparib, Lipadrox) treat recurrent ovarian cancer?

2026-02-01 22:25:32

Check Details
How to deal with stomach pain and discomfort caused by Lynparza (Olaparib, Lipadro) and Lenvatinib

2026-02-01 22:25:32

Check Details
What is the efficacy of olaparib (Olaparib, Lipadro) combined with anlotinib?

2026-02-01 22:25:32

Check Details
How to take the Indian version of Lynparza (Olaparib, Lipadro)

2026-02-01 22:25:32

Check Details
Lynparza (Olaparib, Lipadro): purposes, dosage, side effects, contraindications, etc.

2026-02-01 22:25:32

Check Details
Mavorixafor (Xolremdi) indications, dosage, adverse reactions, interactions, etc.

2026-02-01 22:25:32

Check Details
Clinical trial of Mavorixafor (Xolremdi) in the treatment of WHIM syndrome

2026-02-01 22:25:32

Check Details
Mavorixafor is the treatment of choice for the rare immunodeficiency disorder WHIM syndrome

2026-02-01 22:25:32

Check Details
New Breakthrough Therapy Mavorixafor (Xolremdi) Approved to Treat WHIM Syndrome

2026-02-01 22:25:32

Check Details
Category
相关知识